Commentary on PBT-1 study of high-dose consolidation versus standard therapy in metastatic breast cancer.
Livingston
R
R
Division of Oncology, University of Washington, Seattle 98195-6043, USA.
Crowley
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D016032:Randomized Controlled Trials as Topic; D013019:South Africa; D013997:Time Factors; D014481:United States
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate